Forecasting individual progression trajectories in Huntington disease enables more powered clinical trials.
Ontology highlight
ABSTRACT: Variability in neurodegenerative disease progression poses great challenges for the evaluation of potential treatments. Identifying the persons who will experience significant progression in the short term is key for the implementation of trials with smaller sample sizes. We apply here disease course mapping to forecast biomarker progression for individual carriers of the pathological CAG repeat expansions responsible for Huntington disease. We used data from two longitudinal studies (TRACK-HD and TRACK-ON) to synchronize temporal progression of 15 clinical and imaging biomarkers from 290 participants with Huntington disease. We used then the resulting HD COURSE MAP to forecast clinical endpoints from the baseline data of 11,510 participants from ENROLL-HD, an external validation cohort. W
SUBMITTER: Koval I
PROVIDER: S-EPMC9640581 | biostudies-literature | 2022 Nov
REPOSITORIES: biostudies-literature
ACCESS DATA